Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
nanoparticles
Pharma
Nanoparticles maximize cancer drug's STING in preclinical tests
Researchers have turned to delivery nanoparticles to maximize the anti-cancer STING of a molecule, pointing to a way to unlock the pathway's promise.
Nick Paul Taylor
Oct 31, 2022 9:05am
Oral insulin project finds key to boosting nanoparticle loading
Jun 21, 2022 12:23pm
Genprex pairs gene therapy delivery tech with Keytruda in trial
Apr 5, 2022 9:05am
Enhertu, Takeda, Xtandi and more—Fierce Pharma Asia
Feb 25, 2022 8:55am
Nanoparticles get drugs into the brain to clear HIV reservoirs
Aug 17, 2021 8:45am
Private equity firm buys PTS to expand nanoparticle delivery
May 3, 2021 7:25am
